Review Article

Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer

Table 1

Phenotypes of CD8+ Treg lymphocyte populations and their role in different pathologies.

PathologyAgent/conditionPhenotype of CD8+ regulatory T lymphocytesExert suppressive actionModelReferences

InfectionMycobacteriaCD25+FoxP3+CD39+Inhibit Th1 lymphocyte proliferationHuman[93, 94]
HIVCD28CD127loCD39+Inhibit mononuclear cell proliferationHuman[97]
Epstein-Barr virusFoxP3+Inhibit CD4+ T lymphocyte proliferation and produce IL-10Human[98]
Autoimmune diseaseEAECD28Reduce amount of IFN-γ produced by CD4+ T lymphocytesMouse[101]
EAECD122+Inhibit characteristic IL-7 production of inflammatory process during EAE; inhibit CD4+ T lymphocyte proliferationMouse[102]
Multiple sclerosisCD8+CD28CD39+CD127Inhibit proliferation[103, 104]
SLEFoxP3+Regulate by TGF-βHuman[70]
SLECD25+FoxP3+Suppress production of autoantibodiesHuman[105]
Primary biliary cirrhosisCD28CD39+CD127Suppress proliferationHuman[106]
CancerColorectal cancerCD25+FoxP3+Inhibit CD4+CD25 T lymphocyte and Th1 cytokine productionHuman[110]
Prostate cancerCD25+FoxP3+Inhibit naïve T lymphocyte proliferationHuman[111]
Inoculation with tumor cell linesCD39+Tim-3+PD-1+LAG-3+Exert cytotoxic activityMouse[112]
GVHDAllogeneic cellsLAG-3+FoxP3+CTLA-4+Suppress allogeneic response via CTLA-4Human[39]
Allogeneic cellsCD25+CTLA-4+FoxP3+Inhibit cell proliferation and release of cytokines as IL-1α, IL-17a, IFN-γ, and TNF-αHuman[115]
Allogeneic cellsCD28Inhibit CD4+ T lymphocyte proliferationHuman[10]
Allogeneic cellsCD25+FoxP3+Inhibit allogeneic responseHuman[123]
Allogeneic cellsFoxP3+Inhibit CD4+ and CD8+ T lymphocyte proliferation and CD40, CD80, and CD86 expression in CDMouse[125, 126]

GVHD: graft-versus-host disease; HIV: human immunodeficiency virus; EAE: experimental autoimmune encephalomyelitis.